Matthias Jung

Matthias Jung

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Matthias Jung has a total of 99 co-authors. Here are the top co-authors by number of shared publications:

  • Dan Rujescu

    Department of Psychiatry and Psychotherapy, Division of General Psychiatry, Medical University of Vienna, Vienna, Austria

    27 shared publications
  • Claudia Claus

    Institute of Medical Microbiology and Virology, Medical Faculty, Leipzig University, Leipzig, Germany

    5 shared publications
  • Carla Hartmann

    Institute for Physiological Chemistry (IPC), Medical Faculty of the Martin Luther University Halle-Wittenberg, Halle (Saale), Germany

    4 shared publications
  • Dan Rujescu

    Department of Psychiatry and Psychotherapy, Comprehensive Center for Clinical Neurosciences and Mental Health (C3NMH), Medical University of Vienna, Vienna, Austria

    4 shared publications
  • Insa S. Schroeder

    Department of Biophysics, GSI Helmholtz Centre for Heavy Ion Research, Darmstadt, Germany

    4 shared publications
  • Bernadette Harwardt

    Institute for Physiological Chemistry, Medical Faculty of the Martin, Luther University Halle-Wittenberg, Halle (Saale), Germany

    3 shared publications

Latest Publications

  • Open Access

    Serum biomarkers of seizure-related neuronal damage and astroglial activation in epileptic seizures and epilepsy

    by Annemarie Thaele, Lorenzo Barba, Samir Abu-Rumeileh, Johanna Aschauer, Petra Steinacker, Matthias Jung, Markus Otto


  • Open Access

    Brain capillary endothelial-like cells show altered barrier functionality and reduced transport of amyloid β in late-onset Alzheimer disease

    by Carla Hartmann, Undine Haferkamp, Antje Appelt-Menzel, Janica Barenberg, Andreas Brachner, Toni Ehrhard, Julia Feldhaus, Anna Gerhartl, Thomas Hollemann, Linda Anna Michelle Kulka, et al.

    Background: With the progression of late-onset Alzheimer disease (LOAD), there is a dysregulation and then a breakdown of the blood-brain barrier (BBB). An important pathological feature in the brains of patients is the accumulation of amyloid beta (Aβ) peptides. Their aggregation leads to the formation of particularly harmful Aβ oligomers (Aβ-O). Unfortunately, our understanding of changes in the blood-brain barrier, particularly with regard to the effects of Aβ-O, is still very limited. Methods: This study investigated a LOAD-specific and induced pluripotent stem cell (hiPSC)-based in vitro model of the BBB for disease mechanisms and validated the findings in two independent laboratories. This study also investigated Aβ transport across the BBB. Furthermore, obtained in vitro findings were confirmed in the cerebrospinal fluid proteome of a LOAD patient cohort. Results: Control and LOAD hiPSCs exhibited comparable efficiency in forming brain capillary endothelial-like cells (BCECs). Although transendothelial electrical resistance (TEER) assessments indicated no significant differences in barrier tightness between LOAD and control BCECs, high-throughput multiplex qPCR analysis revealed subtle alterations in barrier integrity. This included changes in various barrier markers, such as mucins (MUC1, MUC20), aquaporins (AQP5, AQP10), junctional transcripts (CLDNs, TJP1, OCLN), and receptors (LRP1, INSR, LSR), which were confirmed in LOAD patients. High-content imaging and flow cytometry indicated reduced cadherin 5 (CDH5) levels in LOAD BCECs. Importantly, the results also highlighted a difference in the transport of Aβ-O across the BBB. Conclusion: This model demonstrates a LOAD-relevant phenotype with decreased Aβ transport and alterations in key transcripts and could thus serve for future translational studies to rescue pathogenic phenotypes.


  • Open Access

    Comparison of Extracellular Vesicles from Induced Pluripotent Stem Cell-Derived Brain Cells

    by Gabriela Xavier, Alexander Navarrete Santos, Carla Hartmann, Marcos L. Santoro, Nicole Flegel, Jessica Reinsch, Annika Majer, Toni Ehrhardt, Jenny Pfeifer, Andreas Simm, et al.

    The pathophysiology of many neuropsychiatric disorders is still poorly understood. Identification of biomarkers for these diseases could benefit patients due to better classification and stratification. Exosomes excreted into the circulatory system can cross the blood–brain barrier and carry a cell type-specific set of molecules. Thus, exosomes are a source of potential biomarkers for many diseases, including neuropsychiatric disorders. Here, we investigated exosomal proteins produced from human-induced pluripotent stem cells (iPSCs) and iPSC-derived neural stem cells, neural progenitors, neurons, astrocytes, microglia-like cells, and brain capillary endothelial cells. Of the 31 exosome surface markers analyzed, a subset of biomarkers were significantly enriched in astrocytes (CD29, CD44, and CD49e), microglia-like cells (CD44), and neural stem cells (SSEA4). To identify molecular fingerprints associated with disease, circulating exosomes derived from healthy control (HC) individuals were compared against schizophrenia (SCZ) patients and late-onset Alzheimer’s disease (LOAD) patients. A significant epitope pattern was identified for LOAD (CD1c and CD2) but not for SCZ compared to HC. Thus, analysis of cell type- and disease-specific exosome signatures of iPSC-derived cell cultures may provide a valuable model system to explore proteomic biomarkers for the identification of novel disease profiles.


  • Open Access

    Human isogenic cells of the neurovascular unit exert transcriptomic cell type-specific effects on a blood-brain barrier in vitro model of late-onset Alzheimer disease

    by Undine Haferkamp, Carla Hartmann, Chaudhry Luqman Abid, Andreas Brachner, Alevtina Höchner, Anna Gerhartl, Bernadette Harwardt, Selin Leckzik, Jennifer Leu, Marco Metzger, et al.

    The function of the blood-brain barrier (BBB) is impaired in late-onset Alzheimer disease (LOAD), but the associated molecular mechanisms, particularly with respect to the high-risk APOE4/4 genotype, are not well understood. For this purpose, we developed a multicellular isogenic model of the neurovascular unit (NVU) based on human induced pluripotent stem cells. The human NVU was modeled in vitro using isogenic co-cultures of astrocytes, brain capillary endothelial-like cells (BCECs), microglia-like cells, neural stem cells (NSCs), and pericytes. Physiological and pathophysiological properties were investigated as well as the influence of each single cell type on the characteristics and function of BCECs. The barriers established by BCECs were analyzed for specific gene transcription using high-throughput quantitative PCR. Co-cultures were found to tighten the barrier of BCECs and alter its transcriptomic profile under both healthy and disease conditions. In vitro differentiation of brain cell types that constitute the NVU was not affected by the LOAD background. The supportive effect of NSCs on the barrier established by BCECs was diminished under LOAD conditions. Transcriptomes of LOAD BCECs were modulated by different brain cell types. NSCs were found to have the strongest effect on BCEC gene regulation and maintenance of the BBB. Co-cultures showed cell type-specific functional contributions to BBB integrity under healthy and LOAD conditions. Cell type-dependent transcriptional effects on LOAD BCECs were identified. Our study suggests that different brain cell types of the NVU have unique roles in maintaining barrier integrity that vary under healthy and LOAD conditions. .


  • Open Access

    Neuronal Stem Cells from Late-Onset Alzheimer Patients Show Altered Regulation of Sirtuin 1 Depending on Apolipoprotein E Indicating Disturbed Stem Cell Plasticity

    by Matthias Jung, Juliane-Susanne Jung, Jenny Pfeifer, Carla Hartmann, Toni Ehrhardt, Chaudhry Luqman Abid, Jenny Kintzel, Anne Puls, Anne Navarrete Santos, Thomas Hollemann, et al.

    Late-onset Alzheimer’s disease (AD) is a complex multifactorial disease. The greatest known risk factor for late-onset AD is the E4 allele of the apolipoprotein E (APOE), while increasing age is the greatest known non-genetic risk factor. The cell type-specific functions of neural stem cells (NSCs), in particular their stem cell plasticity, remain poorly explored in the context of AD pathology. Here, we describe a new model that employs late-onset AD patient-derived induced pluripotent stem cells (iPSCs) to generate NSCs and to examine the role played by APOE4 in the expression of aging markers such as sirtuin 1 (SIRT1) in comparison to healthy subjects carrying APOE3. The effect of aging was investigated by using iPSC-derived NSCs from old age subjects as healthy matched controls. Transcript and protein analysis revealed that genes were expressed differently in NSCs from late-onset AD patients, e.g., exhibiting reduced autophagy-related protein 7 (ATG7), phosphatase and tensin homolog (PTEN), and fibroblast growth factor 2 (FGF2). Since SIRT1 expression differed between APOE3 and APOE4 NSCs, the suppression of APOE function in NSCs also repressed the expression of SIRT1. However, the forced expression of APOE3 by plasmids did not recover differently expressed genes. The altered aging markers indicate decreased plasticity of NSCs. Our study provides a suitable in vitro model to investigate changes in human NSCs associated with aging, APOE4, and late-onset AD.


  • Open Access

    Generation of a set of induced pluripotent stem cell lines from two Alzheimer disease patients carrying APOE4 (MLUi007-J; MLUi008-A) and healthy old donors carrying APOE3 (MLUi009-A; MLUi010-B) to study APOE in aging and disease

    by Matthias Jung, Carla Hartmann, Toni Ehrhardt, Lisa-Maria Peter, Chaudhry Luqman Abid, Bernadette Harwardt, Jana Hirschfeld, Claudia Claus, Undine Haferkamp, Ole Pless, et al.


  • Generation of Neural Stem Cells from Pluripotent Stem Cells for Characterization of Early Neuronal Development

    by Matthias Jung, Jovita Schiller, Carla Hartmann, Jenny Pfeifer, Dan Rujescu

    We describe the protocol for the efficient in vitro differentiation of human neural stem cells (NSCs) from human-induced pluripotent stem cells (iPS cells). NSCs differentiate via neural epithelial progenitors enabling the analysis of early neuronal development. They represent neural progenitor cells, which are capable of differentiating into neurons and glia.


  • Open Access

    Coxsackievirus B3 Infection of Human iPSC Lines and Derived Primary Germ-Layer Cells Regarding Receptor Expression

    by Janik Böhnke, Sandra Pinkert, Maria Schmidt, Hans Binder, Nicole Christin Bilz, Matthias Jung, Uta Reibetanz, Antje Beling, Dan Rujescu, Claudia Claus

    The association of members of the enterovirus family with pregnancy complications up to miscarriages is under discussion. Here, infection of two different human induced pluripotent stem cell (iPSC) lines and iPSC-derived primary germ-layer cells with coxsackievirus B3 (CVB3) was characterized as an in vitro cell culture model for very early human development. Transcriptomic analysis of iPSC lines infected with recombinant CVB3 expressing enhanced green fluorescent protein (EGFP) revealed a reduction in the expression of pluripotency genes besides an enhancement of genes involved in RNA metabolism. The initial distribution of CVB3-EGFP-positive cells within iPSC colonies correlated with the distribution of its receptor coxsackie- and adenovirus receptor (CAR). Application of anti-CAR blocking antibodies supported the requirement of CAR, but not of the co-receptor decay-accelerating factor (DAF) for infection of iPSC lines. Among iPSC-derived germ-layer cells, mesodermal cells were especially vulnerable to CVB3-EGFP infection. Our data implicate further consideration of members of the enterovirus family in the screening program of human pregnancies. Furthermore, iPSCs with their differentiation capacity into cell populations of relevant viral target organs could offer a reliable screening approach for therapeutic intervention and for assessment of organ-specific enterovirus virulence.


  • Open Access

    Glycation Increases the Risk of Microbial Traversal through an Endothelial Model of the Human Blood-Brain Barrier after Use of Anesthetics

    by Veronika Weber, Heidi Olzscha, Timo Längrich, Carla Hartmann, Matthias Jung, Britt Hofmann, Rüdiger Horstkorte, Kaya Bork

    The function of the human blood–brain barrier (BBB), consisting mainly of the basement membrane and microvascular endothelial cells, is to protect the brain and regulate its metabolism. Dysfunction of the BBB can lead to increased permeability, which can be linked with several pathologies, including meningitis, sepsis, and postoperative delirium. Advanced glycation end products (AGE) are non-enzymatic, posttranslational modifications of proteins, which can affect their function. Increased AGE levels are strongly associated with ageing and degenerative diseases including diabetes. Several studies demonstrated that the formation of AGE interfere with the function of the BBB and may change its permeability for soluble compounds. However, it is still unclear whether AGE can facilitate microbial traversal through the BBB and how small compounds including anesthetics modulate this process. Therefore, we developed a cellular model, which allows for the convenient testing of different factors and compounds with a direct correlation to bacterial traversal through the BBB. Our results demonstrate that both glycation and anesthetics interfere with the function of the BBB and promote microbial traversal. Importantly, we also show that the essential nutrient and antioxidant ascorbic acid, commonly known as vitamin C, can reduce the microbial traversal through the BBB and partly reverse the effects of AGE.


  • Faculty Opinions recommendation of The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases.

    by Dan Rujescu, Matthias Jung

    Late-onset Alzheimer’s disease (AD) occurs sporadically and is a complex multifactorial disease. Sporadic AD is not a monogenic defect and is thought to be caused by a number of genetic susceptibilities and environmental factors. One of the first known AD-associated mutations has been described in Apolipoprotein E (APOE), which results in different isoforms of APOE including APOE4. APOE is expressed in many different brain cells suggesting that there is a high diversity of different functions in the related neuronal cell types. The APOE pathway regulates the lipid metabolisms, but in LOAD APOE4 is also involved in in the accumulation of amyloid-beta in the brain. A strong inducer of the APOE pathway is the Triggering receptor expressed on myeloid cells 2 (TREM2), which is expressed on the surface of microglia. Microlgia are responsible for removing plaques, damaged or unnecessary neurons and synapses, and infectious agents. There is evidence that microglia could provide powerful targets for preventing and treating neurodegenerative diseases. Missense mutations in TREM2 are associated with an increased risk for suffering from AD and other forms of dementia. More than 60 TREM2 mutations that have been described in context of neurodegenrative diseases. TREM2 R47H amino acid exchange was first linked to AD in 2013 and disturbs the integrity of the TREM2 protein leading to functional alterations. Further, it has been shown that TREM2 is a master regulator of immune response in the human brain. However, cellular and molecular consequences are poorly understood. Even though APOE4 was discovered many years ago, there is still a lack of knowledge about the disturbed functionality in the context of AD. Krasemann and co-authors aimed at a functional analysis of microglia with focus on the APOE4/TREM2 pathways. Therefore, microglia were studied in mice using models for AD and amyotrophic lateral sclerosis (ALS). First, mouse models for ALS and AD were used to understand the transcriptional changes in ageing and disease in murine primary microglia. This study provides detailed insight into certain genes, gene families, and clusters. The authors revealed a molecular signature with induced APOE and suppressed TGF-beta. Next, the microglial phenotype was observed in murine and human brains. Microglia changed from a homeostatic to a neurodegenerative phenotype in AD. A focused analyses revealed that APOE regulates transcriptional and post-transcriptional program of microglia, which has a strong effect on their phenotype and their functionality. One could conclude that this observation provides a plausible explanation for the high diversity of different APOE functions in different brain cells.